Atorvastatin/Fimasartan

阿托伐他汀/非马沙坦

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAtorvastatin/Fimasartan
Drug Alias Name非马沙坦钾三水合物/阿托伐他汀钙Atorvastatin+BR-A 657Atorvastatin/BR-A 657Atorvastatin+fimasartanFimasartan+atorvastatin +[7] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Fimasartan Potassium TrihydrateAtorvastatin Calcium Hydrate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoryung Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A